TSH Biopharm Corporation Limited (TPEX:8432)

TSH Biopharm Corporation Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	544.18	588.34	576.59	488.9	381.89	396.7
Short-Term Investments	372.13	309.02	195.54	326.86	351.52	328.97
Cash & Short-Term Investments	916.31	897.36	772.12	815.77	733.41	725.67
Cash Growth	33.93%	16.22%	-5.35%	11.23%	1.07%	6.31%
Accounts Receivable	194.83	211.68	208.33	202.55	99.07	108.88
Other Receivables	3.05	2.39	2.18	1.83	1.06	2.98
Receivables	197.89	214.07	210.51	204.38	100.13	111.86
Inventory	165.38	176.08	118.4	107.39	73.22	77.91
Prepaid Expenses	17.64	16.79	9.29	-	-	-
Other Current Assets	8	0.41	3.44	15.37	13.22	28.41
Total Current Assets	1,305	1,305	1,114	1,143	919.97	943.84
Property, Plant & Equipment	39.32	40.41	32.68	41.64	27.36	34.04
Long-Term Investments	192.01	192.63	188.89	179.08	212.06	241.43
Goodwill	247.9	247.9	-	-	-	-
Other Intangible Assets	46.79	39.75	53.64	64.07	3.63	6.18
Long-Term Deferred Tax Assets	4.01	4.01	1.51	1.8	2.01	1.26
Other Long-Term Assets	16.71	12.78	9.39	5.62	4.39	2.64
Total Assets	1,852	1,842	1,400	1,435	1,169	1,229
Accounts Payable	58.16	71.36	51.42	57.64	12.72	7.42
Accrued Expenses	42.03	56.69	35.21	37.4	44.77	48.8
Short-Term Debt	-	-	-	20	-	-
Current Portion of Long-Term Debt	-	-	-	18.85	-	-
Current Portion of Leases	10.81	10.1	7.4	7.32	4.57	4.37
Current Income Taxes Payable	28.56	32.23	2.97	8.02	7.1	15.65
Current Unearned Revenue	3.95	1.04	1.84	5.43	-	-
Other Current Liabilities	120.64	37.48	34.79	50.85	16.64	22.39
Total Current Liabilities	264.14	208.9	133.63	205.5	85.8	98.62
Long-Term Debt	-	-	-	9.6	-	-
Long-Term Leases	9.4	10.33	-	7.36	-	4.42
Total Liabilities	273.54	219.23	133.63	222.46	85.8	103.04
Common Stock	383.98	383.98	383.98	383.98	383.98	383.98
Additional Paid-In Capital	459.61	459.55	459.5	459.44	459.36	458.98
Retained Earnings	455.89	480.68	204.14	228.37	224.08	266.63
Comprehensive Income & Other	41.69	67.58	59.98	22.58	16.21	16.76
Total Common Equity	1,341	1,392	1,108	1,094	1,084	1,126
Minority Interest	237.24	231.18	158.63	118.31	-	-
Shareholders' Equity	1,578	1,623	1,266	1,213	1,084	1,126
Total Liabilities & Equity	1,852	1,842	1,400	1,435	1,169	1,229
Total Debt	20.21	20.43	7.4	63.13	4.57	8.78
Net Cash (Debt)	896.1	876.93	764.73	752.64	728.84	716.89
Net Cash Growth	32.95%	14.67%	1.60%	3.27%	1.67%	5.68%
Net Cash Per Share	23.30	22.81	19.90	19.57	18.96	18.65
Filing Date Shares Outstanding	38.4	38.4	38.4	38.4	38.4	38.4
Total Common Shares Outstanding	38.4	38.4	38.4	38.4	38.4	38.4
Working Capital	1,041	1,096	980.13	937.41	834.17	845.22
Book Value Per Share	34.93	36.25	28.85	28.50	28.22	29.33
Tangible Book Value	1,046	1,104	1,054	1,030	1,080	1,120
Tangible Book Value Per Share	27.25	28.76	27.45	26.83	28.13	29.17
Land	5.85	5.85	5.85	5.85	5.85	5.85
Buildings	14.2	14.2	14.2	13.94	13.94	13.94
Machinery	48.55	47.68	33.13	31.41	22.48	22.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.